Xinxin Ke

Xinxin Ke

Auto-generated profile, based on publicly available information

Xinxin Ke

Children’s Hospital, National Clinical Research Center for Child Health, Zhejiang University School of Medicine, Hangzhou, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2021 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
XKXinxin Ke
Xinxin Ke
THTao Hu
Tao Hu
MJMizu Jiang
Mizu Jiang
Cyclic GMP‐AMP synthase (cGAS)–stimulator of interferon genes (STING) signaling pathway has emerged as a key DNA‐sensing machinery in innate immunity. Activation of cGAS–STING signaling pathway mediates the production of interferons and proinflammatory cytokines. Although cGAS–STING signaling pathway shows critical function in the maintenance of gut homeostasis, overactive cGAS–STING signaling pathway leads to gastrointestinal (GI) inflammation. Harnessing the effect and mechanism of the cGAS–STING signaling pathway could be beneficial for the development of novel strategies for the treatment of GI diseases. This review presents recent advances regarding the role of cGAS–STING signaling pathway in GI inflammatory disease and cancers and describes perspective therapeutic strategies targeting the signaling pathway.

4 February 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
THTao Hu
Tao Hu
XKXinxin Ke
Xinxin Ke
YYYingying Yu
Yingying Yu
HFHongmei Feng
Hongmei Feng
SZSenfeng Zhang
Senfeng Zhang
CHChunyi Hu
Chunyi Hu
In an era where swift and precise diagnostic capabilities are paramount, we introduce NAPTUNE (Nucleic acids and Protein Biomarkers Testing via Ultra-sensitive Nucleases Escalation), an innovative platform for the amplification-free detection of nucleic acids and protein biomarkers in less than 45 minutes. Using a tandem cascade of endonucleases, NAPTUNE employs apurinic/apyrimidinic endonuclease 1 (APE1) to generate DNA guides, enabling the detection of target nucleic acids at femtomolar levels. The sensitivity is elevated to attomolar levels through the action of Pyrococcus furiosus Argonaute (PfAgo), which intensifies probe cleavage, thereby boosting both sensitivity and specificity within an innovative in-situ cascade circuit. This technology not only streamlines rapid, onsite diagnostics without pre-amplification but also demonstrates exceptional accuracy in identifying a broad spectrum of nucleic acids and crucial cancer-related protein biomarkers directly from clinical samples. The development of a portable device for point-of-care testing further underscores NAPTUNE’s potential to transform diagnostic processes, especially in resource-limited environments, marking a significant diversity forward in medical diagnostics and patient care.